<http://www.wikidata.org/entity/Q65470016>	<http://www.w3.org/2000/01/rdf-schema#label>	"Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer"@nl .
<http://www.wikidata.org/entity/Q65470016>	<http://www.wikidata.org/prop/P6153>	<http://www.wikidata.org/entity/statement/Q65470016-8699CBD7-1C83-4ED7-89E9-C8F38E2ED73F> .
<http://www.wikidata.org/entity/Q65470016>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://wikiba.se/ontology#Item> .
<http://www.wikidata.org/entity/Q65470016>	<http://www.w3.org/2004/02/skos/core#prefLabel>	"Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer"@en .
<http://www.wikidata.org/entity/Q65470016>	<http://schema.org/description>	"klinisch onderzoek"@nl .
<http://www.wikidata.org/entity/Q65470016>	<http://www.wikidata.org/prop/direct/P580>	"2007-10-01T00:00:00Z"^^<http://www.w3.org/2001/XMLSchema#dateTime> .
<http://www.wikidata.org/entity/Q65470016>	<http://www.wikidata.org/prop/direct/P1132>	"52"^^<http://www.w3.org/2001/XMLSchema#decimal> .
<http://www.wikidata.org/entity/Q65470016>	<http://www.w3.org/2000/01/rdf-schema#label>	"Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer"@en .
<http://www.wikidata.org/entity/Q65470016>	<http://schema.org/description>	"ensayu cl\u00EDnicu"@ast .
<http://www.wikidata.org/entity/Q65470016>	<http://www.wikidata.org/prop/P2899>	<http://www.wikidata.org/entity/statement/Q65470016-70329BF6-8DD0-4FBF-8473-895B04161B2A> .
<http://www.wikidata.org/entity/Q65470016>	<http://schema.org/description>	"\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk .
<http://www.wikidata.org/entity/Q65470016>	<http://www.wikidata.org/prop/P4844>	<http://www.wikidata.org/entity/statement/Q65470016-BA67FD13-9A43-4759-BE1B-2E5FB2F044AF> .
<http://www.wikidata.org/entity/Q65470016>	<http://www.wikidata.org/prop/direct/P4844>	<http://www.wikidata.org/entity/Q412197> .
<http://www.wikidata.org/entity/Q65470016>	<http://www.wikidata.org/prop/direct/P4844>	<http://www.wikidata.org/entity/Q413299> .
<http://www.wikidata.org/entity/Q65470016>	<http://www.wikidata.org/prop/P580>	<http://www.wikidata.org/entity/statement/Q65470016-0EAF4084-4303-4A29-96AB-D42B987B6314> .
<http://www.wikidata.org/entity/Q65470016>	<http://www.wikidata.org/prop/P3098>	<http://www.wikidata.org/entity/statement/Q65470016-DFD7E3D5-BF46-4D33-9D23-27C074C39160> .
<http://www.wikidata.org/entity/Q65470016>	<http://www.wikidata.org/prop/direct/P2899>	"20"^^<http://www.w3.org/2001/XMLSchema#decimal> .
<http://www.wikidata.org/entity/Q65470016>	<http://www.wikidata.org/prop/P4844>	<http://www.wikidata.org/entity/statement/Q65470016-A3FD26E4-980D-48AE-AED2-8BB66832D9DF> .
<http://www.wikidata.org/entity/Q65470016>	<http://www.wikidata.org/prop/direct/P3098>	"NCT00569335" .
<http://www.wikidata.org/entity/Q65470016>	<http://www.wikidata.org/prop/P8363>	<http://www.wikidata.org/entity/statement/Q65470016-85B8E1FE-4DA6-47A7-8942-1AEBD06D2DD5> .
<http://www.wikidata.org/entity/Q65470016>	<http://www.wikidata.org/prop/P31>	<http://www.wikidata.org/entity/statement/Q65470016-70556FC5-4D2B-4608-9677-C2099F15885D> .
<http://www.wikidata.org/entity/Q65470016>	<http://www.wikidata.org/prop/direct/P6099>	<http://www.wikidata.org/entity/Q42824440> .
<http://www.wikidata.org/entity/Q65470016>	<http://www.wikidata.org/prop/direct/P6153>	<http://www.wikidata.org/entity/Q55454195> .
<http://www.wikidata.org/entity/Q65470016>	<http://schema.org/description>	"clinical trial"@en .
<http://www.wikidata.org/entity/Q65470016>	<http://schema.org/name>	"Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer"@nl .
<http://www.wikidata.org/entity/Q65470016>	<http://www.wikidata.org/prop/direct/P31>	<http://www.wikidata.org/entity/Q30612> .
<http://www.wikidata.org/entity/Q65470016>	<http://www.wikidata.org/prop/P17>	<http://www.wikidata.org/entity/statement/Q65470016-7CEC3F1D-D245-4793-925B-E027DDC37AEA> .
<http://www.wikidata.org/entity/Q65470016>	<http://www.wikidata.org/prop/direct/P17>	<http://www.wikidata.org/entity/Q17> .
<http://www.wikidata.org/entity/Q65470016>	<http://www.wikidata.org/prop/P1132>	<http://www.wikidata.org/entity/statement/Q65470016-4B31689C-1EF6-450E-9003-ABB2EFF934A9> .
<http://www.wikidata.org/entity/Q65470016>	<http://www.wikidata.org/prop/direct/P582>	"2010-03-01T00:00:00Z"^^<http://www.w3.org/2001/XMLSchema#dateTime> .
<http://www.wikidata.org/entity/Q65470016>	<http://schema.org/name>	"Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer"@en .
<http://www.wikidata.org/entity/Q65470016>	<http://www.w3.org/2004/02/skos/core#prefLabel>	"Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer"@nl .
<http://www.wikidata.org/entity/Q65470016>	<http://www.wikidata.org/prop/P582>	<http://www.wikidata.org/entity/statement/Q65470016-DD4561FC-40D8-4E19-9C9B-E8F86B54F4C4> .
<http://www.wikidata.org/entity/Q65470016>	<http://www.wikidata.org/prop/P1476>	<http://www.wikidata.org/entity/statement/Q65470016-A9C0AA6C-9A48-410C-B2EA-1B8A49B6B03A> .
<http://www.wikidata.org/entity/Q65470016>	<http://www.wikidata.org/prop/direct/P1476>	"Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer"@en .
<http://www.wikidata.org/entity/Q65470016>	<http://www.wikidata.org/prop/P6099>	<http://www.wikidata.org/entity/statement/Q65470016-43BD360D-3927-42F7-82F9-0E950D3FC2E6> .
<http://www.wikidata.org/entity/Q65470016>	<http://www.wikidata.org/prop/direct/P8363>	<http://www.wikidata.org/entity/Q78089383> .